title: [Molecular genetics of hereditary breast carcinoma].
abstract: Breast cancer is the most common malignancy among women. Genetic predisposition is considered to account for 5-10% of all cases while the majority of these cancers are sporadic and caused by complex interactions of exogenous and endogenous factors. The inherited predisposition can be due to germline mutations in one of several cancer susceptibility genes. For high risk families the two most important genes are BRCA1 on chromosome 17q, which confers a high risk of both, breast and ovarian cancer and BRCA2 on chromosome 13 associated with high penetrance of breast cancer but lower risk of ovarian cancer. A high risk of breast cancer is conferred by mutations in the p53 tumor suppressor gene as part of the rare Li-Fraumeni-syndrome, and possibly also by the estrogen receptor gene. Other cancer genes associated with a less increased risk of breast cancer are the autosomal recessive ataxia telangiectasia (AT) gene and the HRAS1 gene. Germline mutations in BRCA1 and BRCA2 account for the majority of families with multiple cases of breast and/or ovarian cancer and also at least 10% of cases below the age of 40 years. Genetic testing for BRCA1 mutations is not generally recommended except for women with a strong family history. The aim for the management of familial breast cancer should be the establishment of interdisciplinary teams to cover genetic counseling, molecular analysis, onco-surgical therapy, psychosocial support and clinical follow-up.
authors.affiliation: Universitätsklinikum Carl Gustav Carus, Klinik für Viszeral-, Thorax- und Gefässchirurgic, Heidelberg.
authors.forename: M
authors.initials: M
authors.lastname: Hampl
authors.forename: J
authors.initials: J
authors.lastname: Chang-Claude
authors.forename: P
authors.initials: P
authors.lastname: Schwarz
authors.forename: H D
authors.initials: HD
authors.lastname: Saeger
authors.forename: H K
authors.initials: HK
authors.lastname: Schackert
mesh_terms: D019313:BRCA1 Protein / Q000235:genetics; D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000235:genetics*; D002882:Chromosomes, Human, Pair 13; D002886:Chromosomes, Human, Pair 17; D004252:DNA Mutational Analysis; D005260:Female; D005817:Genetic Counseling; D005819:Genetic Markers / Q000235:genetics; D005820:Genetic Testing; D006801:Humans; D008967:Molecular Biology; D009363:Neoplasm Proteins / Q000235:genetics; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics*; D012307:Risk Factors; D014157:Transcription Factors / Q000235:genetics
chemical_list: D019313:BRCA1 Protein; D024682:BRCA2 Protein; D005819:Genetic Markers; D009363:Neoplasm Proteins; D014157:Transcription Factors